Cargando…
A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination
While morbidity and mortality associated with measles and rubella (MR) have dramatically decreased, there are still >100 000 estimated deaths due to measles and an estimated 100 000 infants born with congenital rubella syndrome annually. Given highly effective MR vaccines, the primary barrier to...
Autores principales: | Prausnitz, Mark R, Goodson, James L, Rota, Paul A, Orenstein, Walter A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497860/ https://www.ncbi.nlm.nih.gov/pubmed/32622318 http://dx.doi.org/10.1016/j.coviro.2020.05.005 |
Ejemplares similares
-
Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa
por: Richardson, Lauren Christine, et al.
Publicado: (2020) -
Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]
por: Adigweme, Ikechukwu, et al.
Publicado: (2022) -
Strengthening routine immunization through measles-rubella elimination
por: Biellik, Robin J., et al.
Publicado: (2018) -
Innovations in vaccine delivery: increasing access, coverage, and equity and lessons learnt from measles and rubella elimination
por: Goodson, James L., et al.
Publicado: (2022) -
Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016–2018
por: Brown, Kevin E., et al.
Publicado: (2019)